Clinical Trials Logo
  1. Home
  2. Respiratory Insufficiency
  3. NCT00665119
  4. Details
NCT00665119 Clinical Trial

Effects of Remifentanil on Respiratory Function in Mechanically Ventilated Patients

Respiratory Insufficiency Clinical Trial

Official title:
Effects of Remifentanil on Breathing Pattern, Respiratory Effort and Gas Exchange in Mechanically Ventilated Patients.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00665119
Other study ID # FP-TIP-01
Secondary ID
Status Completed
Phase Phase 4
First received April 18, 2008
Last updated December 17, 2008
Start date April 2008
Est. completion date October 2008

Study information
Verified date December 2008
Source Fondazione Poliambulanza Istituto Ospedaliero
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

Sedation is widely used in mechanically ventilated patients. Propofol, benzodiazepines and opioids are the most used drugs. The study hypothesis is that sedation with remifentanil (an opioid drug) could improved respiratory pattern and effort in mechanically ventilated patients with rapid shallow breathing or high respiratory rate.

Recruitment information / eligibility
Status Completed
Enrollment 14
Est. completion date October 2008
Est. primary completion date October 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- pressure support ventilation or CPAP

- respiratory rate > 35.min-1

- respiratory rate/tidal volume > 105

Exclusion Criteria:

- vasoactive agents (dopamine lower than 5 mcg.kg-1.min-1 is not considered as vasoactive agent)

- body temperature > 38 °C

- Glasgow Coma Scale < 9

- FIO2 > 0.6

- PEEP > 10 cmH2O

- pH < 7.30

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• remifentanil
0.05 mcg.kg-1.min-1 for 30 minutes by continuous endovenous infusion
• placebo
NaCl 0.9 %

Locations
Country Name City State
Italy Intensive Care Unit, Fondazione Poliambulanza Istituto Ospedaliero Brescia

Sponsors (1)
Lead Sponsor Collaborator
Fondazione Poliambulanza Istituto Ospedaliero

Country where clinical trial is conducted

Italy, 

Outcome
Type Measure Description Time frame Safety issue
Primary respiratory rate/tidal volume before and after remifentanil infusion; before and after placebo infusion. No
Primary pressure-time product before and after remifentanil infusion; before and after placebo infusion. No
Secondary double product of respiratory system before and after remifentanil infusion; before and after placebo infusion. No
Secondary dynamic intrinsic PEEP before and after remifentanil infusion; before and after placebo infusion. No
Secondary adverse events during all the study period Yes
Secondary arterial pH before and after remifentanil infusion; before and after placebo infusion. Yes
Secondary level of sedation (RASS) before and after remifentanil infusion; before and after placebo infusion. Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05904652 - High Flow Nasal Oxygen at Extubation for Adults Requiring a Breathing Tube for Treating Severe Breathing Difficulties N/A
Completed NCT04030208 - Evaluating Safety and Efficacy of Umbulizer in Patients Requiring Intermittent Positive Pressure Ventilation N/A
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT02930525 - Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation N/A
Recruiting NCT02539732 - Prediction of Outcome of Weaning From Mechanical Ventilation Using the Electrical Activity of the Diaphragm
Enrolling by invitation NCT02290236 - Monitored Saturation Post-ICU N/A
Completed NCT02056119 - RCT of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit N/A
Terminated NCT01583088 - Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation Phase 3
Withdrawn NCT00990119 - High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD) N/A
Completed NCT01411722 - Electrical Activity of the Diaphragm During the Weaning Period Phase 2
Completed NCT00741949 - Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol TCI in Patient With AHRF Phase 3
Recruiting NCT00339053 - Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair Phase 4
Recruiting NCT00187434 - Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP) N/A
Completed NCT02687802 - Respiratory Mechanics and Patient-ventilator Asynchrony Index in Patients With Invasive Mechanical Ventilation
Not yet recruiting NCT05906030 - Diaphragm Dysfunction and Ultrasound Perioperatively
Completed NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Completed NCT02845375 - Effect of Neuromuscular Blockade and Reversal on Breathing Phase 4
Recruiting NCT03309423 - Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU? N/A
Completed NCT04115969 - Outcome After Non-invasive Ventilation.